Pilot trial of high-dose vitamin C in critically ill COVID-19 patients.

Jing ZhangXin RaoYiming LiYuan ZhuFang LiuGuangling GuoGuoshi LuoZhongji MengDaniel De BackerHui XiangZhi-Yong Peng

Published in: Annals of intensive care (2021)

This pilot trial showed that HDIVC failed to improve IMVFD28, but might show a potential signal of benefit in oxygenation for critically ill patients with COVID-19 improving PaO2/FiO2 even though.

Keyphrases

high dose
sars cov
low dose
stem cell transplantation
blood flow
human health
risk assessment